Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Double- Blind, Placebo- Controlled Study of Montelukast on Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera® (Dimethyl Fumarate) Delayed Release Capsules

NCT02410278 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT02410278
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02410278 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Double- Blind, Placebo- Controlled Study of Montelukast on Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera® (Dimethyl Fumarate) Delayed Release Capsules
Lead sponsor
Biogen
Phase
Phase 4
Overall status
Completed
Start date
March 12, 2015
Completion date
April 27, 2017
Enrollment
102 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis